179
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Assessment of Sexual Dysfunction Symptoms in Female Drug Users: Standardized vs. Unstandardized Methods

, , , &

References

  • Abdo, C. H. N. ( 2004). Estudo da vida sexual do brasileiro (EVSB). [Study of Brazilians' sexual life]. São Paulo, Brazil: Editora Bragantini.
  • American Psychiatric Association. ( 2000). Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: Author.
  • Clark, B. C., Perkins, A., McCullum-Smith, C. B., Islam, A. M., Sung, J., & Cropsey, K. L. ( 2012). What does self-identified drug of choice tell us about individuals under community corrections supervision? Journal Addiction of Medicine, 6(1), 57–67.
  • Cohen, S., Kühn, K. U., Sträter, B., Scherbaum, N., & Weig, W. ( 2010). Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances. Nervenarzt Journal, 81(9), 1129–1137.
  • Diehl, A., Cordeiro, D. C., & Laranjeira, R. ( 2011). Dependência química: prevenção, tratamento e políticas públicas. Porto Alegre, Brazil: ARTMED.
  • Diehl, A., Silva, R. L., & Laranjeira, R. ( 2013). Female sexual dysfunction in patients with substance-related disorders. Clinics (São Paulo), 68(2), 205–212.
  • Finger, W. W., Lund, M., & Slagle, M. A. ( 1997). Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice. Journal of Family Practice, 44(1), 33–43.
  • Giuliano, F. ( 2013). Questionnaires in sexual medicine. Progrés in Urologie, 23(9), 811–821.
  • Gonzalez, A., Barinas, J., & O'Cleirigh, C. ( 2011). Substance use: impact on adherence and HIV medical treatment. Current HIV/AIDS Reports, 8, 223–234.
  • Harte, C. B., & Meston, C. M. ( 2008). The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: Results from a randomized, double-blind, placebo-controlled, cross-over trial. Journal of Sex Medicine, 5(5), 1184–1197.
  • Harte, C. B., & Meston, C. M. ( 2012). Association between smoking cessation and sexual health in men. British Journal of Urology International, 109(6), 888–896, http://dx.doi.org/10.1111/j.1464-410X.2011.10503.x
  • Harvey, D. B. ( 2009). Sexual health in drug and alcohol treatment:Ggroup facilitator's manual. New York: Springer.
  • Hayes, R. D., Bennett, C. M., Fairley, C. K., & Dennerstein, L. ( 2006). What can prevalence studies tell us about female sexual difficulty and dysfunction? Journal of Sex Medicine, 3(4), 589–595.
  • Humburg, J. ( 2010). Female sexual dysfunction. Therapeusthiche Umschau, 67(1), 45–51. http://dx.doi: 10.1024/0040-5930/a000009.
  • INPAD. ( 2012). II Levantamento Nacional de Alcool e Drogas (LENAD). Retrieved March 12, 2014, from http://inpad.org.br/lenad/cocaina-e-crack/resultados-preliminares/
  • Kadri, N., Mchichi, A. K. H., & Mchakra, T. S. ( 2002). Women's sexual dysfunction: A population-based epidemiological study. Archives Women Mental Health, 5, 59–63.
  • Kopetz, C. E., Reynolds, E. K., Hart, C. L., Kruglanski, A. W., & Lejuez, C. W. ( 2010). Social context and perceived effects of drugs on sexual behavior among individuals who use both heroin and cocaine. Experimental and Clinical Psychopharmacology, 18(3), 214–220.
  • Lamont, J. ( 2012). Female sexual health consensus clinical guidelines. Journal of Obstetric and Gynaecology Canadian, 34(8), 769–775.
  • Latif, E. Z., & Diamond, M. P. ( 2013). Arriving at the diagnosis of female sexual dysfunction. Fertility and Sterility. 100(4), 898–904. http://dx.doi.org/10.1016/j.fertnstert.2013.08.006
  • Lau, J. T., Kim, J. H., & Tsui, H. Y. ( 2005). Prevalence, health outcomes, and patterns of psychotropic substance use in a Chinese population in Hong Kong: A population-based study. Journal of Substance Use Misuse, 40(2), 187–209. http://dx.doi.org/10.1081/JA-200048454
  • Laumann, E., Levinson, W., Lindau, S., O'Muircheartaigh, C., Schumm, L., & Waite, L. ( 2007). A study of sexuality and health among older adults in the United States. New England Journal of Medicine, 357(8), 762–774.
  • Laumann, E. O., Paik, A., & Rosen, R. C. ( 1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association, 281(6), 537–544. http://dx.doi.org/10.1001/jama.281.6.537
  • Leaffer, T. ( 1982). Denial in substance abuse and sexual dysfunction. Journal of Psychoactive Drugs, 14(1/2), 143–151.
  • Meneses-Gaya, I. C., Zuardi, A. W., Loureiro, S. R., & Crippa, J. A. ( 2009). Psychometric properties of the Fagerström Test for Nicotine Dependence. Brazilian Journal of Pneumonology, 35(1), 73–82.
  • Nappo, S. A., Sanchez, Z., & Oliveira, L. G. ( 2011). Crack, AIDS, and women in São Paulo, Brazil. Journal of Substance Use & Misuse, 46(4), 476–485.
  • Niv, N., & Hser, Y. I. ( 2007). Women-only and mixed-gender drug abuse treatment programs: Service needs, utilization and outcomes. Journal of Drug and Alcohol Dependence, 87(2/3), 194–201. http://dx.doi.org/10.1016/j.drugalcdep.2006.08.017
  • Rosa-Oliveira, L. Q., Presti, P. F., Antunes, I. R., Carbonari, G. C., Imada, A. C., Maeda, M. Y, … Doering-Silveira, J. ( 2011). Reliability and dimensionality of the Short Alcohol Dependence Data (SADD) questionnaire in a clinical sample of hospitalized patients: Using the SADD in a general hospital setting. Revista Brasileira de Psiquiatria, 33(1), 68–71.
  • Thakar, R. ( 2009). Review of current status of female sexual dysfunction evaluation in urogynecology. International Urogynecology Journal of Pelvic Floor Dysfunction, 20(Suppl.), S27–S31.
  • United Nations Office on Drugs and Crime – UNODC. ( 2012). Word Drugs Report 2012. Retrieved Jan 12, 2014, from http://www.unodc.org/documents/southerncone//Topics_drugs/WDR/2012/WDR_2012_web_small.pdf
  • Wilsnack, S. C., Klassen, A. D., Schur, B. E., & Wilsnack, R. W. ( 1991). Predicting onset and chronicity of women's problem drinking: A five-year longitudinal analysis. American Journal of Public Health, 81(3), 305–318.
  • Yudko, E., Lozhkina, O., & Fouts, A. ( 2007). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment, 32(2), 189–198.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.